Urothelial Cancer Latest Advances

Long-term impact of synchronous and metachronous bladder cancer on prognosis after radical nephroureterectomy for upper urinary tract urothelial carcinoma: results from a large population-based cohort in China: Erratum.

Journal: International journal of surgery (London, England)

Published: January 23, 2026

Killing cancer takes guts: lessons learned from the manipulation of gut microbiome and immunotherapy for the future of urothelial carcinoma.

Journal: Oncoimmunology

Published: January 21, 2026

Cardiac metastasis of urothelial carcinoma mimicking ST-elevation myocardial infarction.

Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti

Published: January 19, 2026

Current Landscape of Sequential Treatment Strategy in Metastatic Urothelial Carcinoma

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: January 19, 2026

Erdafitinib or Erdafitinib Plus Cetrelimab for Patients With Metastatic Urothelial Carcinoma and FGFR Alterations: Final Results From the Phase II NORSE Study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: January 15, 2026

Predictors and Patterns of Nonurothelial Recurrence After Nephroureterectomy for Upper Tract Urothelial Carcinoma (UCAN Collaboration): Erratum.

Journal: The Journal of urology

Published: January 09, 2026

Transvascular endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) to confirm urothelial carcinoma metastasis to the pulmonary artery.

Journal: BMJ case reports

Published: January 09, 2026

Sarcomatoid urothelial carcinoma: advances and challenges.

Journal: Current opinion in urology

Published: January 08, 2026

Nectin-4 PET for predicting enfortumab vedotin dose-response in urothelial carcinoma.

Journal: Science advances

Published: January 07, 2026

Clinical pathological expert consensus on HER2 immunohistochemical testing in urothelial carcinoma(2026 version)

Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology

Published: January 06, 2026

Transitional cell carcinoma in distal urethra after previous excision of HPV related condyloma: Is there a link between human papilloma virus (HPV) and transitional cell carcinoma (TCC)?

Journal: Urologia

Published: January 06, 2026

Auto-Immune Pancreatitis with Pseudo-Tumoral Mass Induced by Pembrolizumab in a Woman suffering from Metastatic Urothelial Carcinoma: Case Report and Literature survey.

Journal: Acta gastro-enterologica Belgica

Published: January 06, 2026

Urothelial Cancer Latest Advances

Find the Latest Research About Urothelial Cancer

Long-term impact of synchronous and metachronous bladder cancer on prognosis after radical nephroureterectomy for upper urinary tract urothelial carcinoma: results from a large population-based cohort in China: Erratum.

Long-term impact of synchronous and metachronous bladder cancer on prognosis after radical nephroureterectomy for upper urinary tract urothelial carcinoma: results from a large population-based cohort in China: Erratum.

Killing cancer takes guts: lessons learned from the manipulation of gut microbiome and immunotherapy for the future of urothelial carcinoma.

Killing cancer takes guts: lessons learned from the manipulation of gut microbiome and immunotherapy for the future of urothelial carcinoma.

Cardiac metastasis of urothelial carcinoma mimicking ST-elevation myocardial infarction.

Cardiac metastasis of urothelial carcinoma mimicking ST-elevation myocardial infarction.

Current Landscape of Sequential Treatment Strategy in Metastatic Urothelial Carcinoma

Current Landscape of Sequential Treatment Strategy in Metastatic Urothelial Carcinoma

Erdafitinib or Erdafitinib Plus Cetrelimab for Patients With Metastatic Urothelial Carcinoma and FGFR Alterations: Final Results From the Phase II NORSE Study.

Erdafitinib or Erdafitinib Plus Cetrelimab for Patients With Metastatic Urothelial Carcinoma and FGFR Alterations: Final Results From the Phase II NORSE Study.

Predictors and Patterns of Nonurothelial Recurrence After Nephroureterectomy for Upper Tract Urothelial Carcinoma (UCAN Collaboration): Erratum.

Predictors and Patterns of Nonurothelial Recurrence After Nephroureterectomy for Upper Tract Urothelial Carcinoma (UCAN Collaboration): Erratum.

Transvascular endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) to confirm urothelial carcinoma metastasis to the pulmonary artery.

Transvascular endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) to confirm urothelial carcinoma metastasis to the pulmonary artery.

Sarcomatoid urothelial carcinoma: advances and challenges.

Sarcomatoid urothelial carcinoma: advances and challenges.

Nectin-4 PET for predicting enfortumab vedotin dose-response in urothelial carcinoma.

Nectin-4 PET for predicting enfortumab vedotin dose-response in urothelial carcinoma.

Clinical pathological expert consensus on HER2 immunohistochemical testing in urothelial carcinoma(2026 version)

Clinical pathological expert consensus on HER2 immunohistochemical testing in urothelial carcinoma(2026 version)

Transitional cell carcinoma in distal urethra after previous excision of HPV related condyloma: Is there a link between human papilloma virus (HPV) and transitional cell carcinoma (TCC)?

Transitional cell carcinoma in distal urethra after previous excision of HPV related condyloma: Is there a link between human papilloma virus (HPV) and transitional cell carcinoma (TCC)?

Auto-Immune Pancreatitis with Pseudo-Tumoral Mass Induced by Pembrolizumab in a Woman suffering from Metastatic Urothelial Carcinoma: Case Report and Literature survey.

Auto-Immune Pancreatitis with Pseudo-Tumoral Mass Induced by Pembrolizumab in a Woman suffering from Metastatic Urothelial Carcinoma: Case Report and Literature survey.